My son has autism. He deserves better than RFK Jr.'s ignorance.
He thinks on a macroscale about the injustices of the world and how we should lead with kindness. And like many of his peers with a similar condition, he thinks about things on a microscale — he can solve complex math with ease, has a deep knowledge of intricate storylines and lore from a multitude of cultures and literary sources, and he has a very defined understanding of what is right and what is wrong.
So when I heard Robert F. Kennedy Jr. recently claim that people with autism 'will never pay taxes, never hold a job, never go on a date, or use a toilet unassisted,' I wasn't just offended. I was heartbroken — and furious.
This is my son we're talking about. And millions of others like him. They are not statistics. They are not burdens. They are not broken. They are people.
Kennedy's comments don't reflect science, compassion or truth. They reflect ignorance. And ignorance at this level, when held by someone in his position, is dangerous.
Need a break? Play the USA TODAY Daily Crossword Puzzle.
Opinion: Make Indiana Healthy Again is about cost-cutting, not wellness
Autism is a spectrum. That's not a metaphor — it's a medical reality. Some individuals do need lifelong support. Others live independently, pursue careers, fall in love and raise families. Many are somewhere in between. According to the Centers for Disease Control, about 1 in 36 children in the U.S. are diagnosed with autism, and there's growing research into how autistic adults thrive when supported with inclusive education, employment opportunities and community engagement.
But reducing every autistic person to a hopeless stereotype isn't just wrong. It causes actual harm. It undermines inclusion. It increases stigma. And it sends a message — to my son and to others like him — that they're not worth the effort.
That's unacceptable.
My son deserves better. So does every person with autism. So do the parents, educators, therapists, and communities working every day to support them — not 'fix' them, but meet them where they are and help them grow.
Autism doesn't need to be "cured." It needs to be understood. And autistic people don't need pity — they need opportunity, support and respect. They need people in power to stop speaking about them without listening to them.
To be clear, I'm not suggesting that autism isn't without challenges. We know the realities. But we also know the beauty, the resilience, the insight that comes from seeing the world differently. My son has taught me more about patience, perception, and empathy than any book, classroom, or has-been politician ever could.
Opinion: If Braun wants to make Indiana healthy again, here's how to do it
So here's my message to Kennedy and anyone else who sees autism as a tragedy: Spend a day with someone like my son. Talk to autistic adults. Visit an inclusive classroom. Walk into that experience with curiosity, not assumptions.
Because the problem isn't autism.
The problem is the way people talk about it.
It's time we stop talking about autism like it's the end of something. It's time to listen to autistic voices. It's time to elevate stories that show the full humanity of people across the spectrum. For our family — and for so many others — it's simply a different beginning. One filled with joy, complexity and, yes, extraordinary love.
Anyone who can't see that shouldn't be speaking for our future.
Joseph Ball lives with his family on the northwest side of Indianapolis. He is a marketing and communications manager, has worked as the digital editor for Indianapolis Monthly and is chair of Tonic Ball, a charitable music festival that benefits Second Helpings.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
21-year-old congressional intern fatally shot in Washington D.C., police say
A 21-year-old congressional intern was fatally shot in Washington, D.C. on Monday night, police say. Eric Tarpinian-Jachym of Granby, Massachusetts was shot around 10 p.m. on Monday, June 30 near Washington D.C.'s Mount Vernon Square, according to the Metropolitan Police Department of the District of Columbia. After lifesaving measures failed, Tarpinian-Jachym died at a hospital on Tuesday, July 1. At the scene, authorities also located an adult female and 16-year-old male who were shot. They are being treated for their injuries. In a preliminary investigation, detectives believe Tarpinian-Jachym was caught in the middle of a shooting and was not the intended target. A suspect vehicle has been recovered. As of Thursday, July 3, police did not have any more information to share. The Metropolitan Police Department is asking anyone who may have information about the shooting to call 202-727-9099 or text the department's tip line at 50411. The police department is offering a $25,000 reward to anyone who can provide information that leads to an arrest and conviction of the person or group of people associated with the shooting. Tarpinian-Jachym was a senior at the University of Massachusetts Amhers' Isenberg School of Management. According to his LinkedIn profile, Tarpinian-Jachym was pursuing a degree in finance and political science. Tarpinian-Jachym was in D.C. completing an internship for Kansas Rep. Ron Estes, the representative's website states. On Wednesday, Estes issued a statement sharing his condolences to Tarpinian-Jachym's family. "I will remember his kind heart and how he always greeted anyone who entered our office with a cheerful smile," Estes said in a statement. "We are grateful to Eric for his service to Kansas' 4th District and the country." Former Kansas Gov. Jeff Colyer also issued a statement about Tarpinian-Jachym's tragic death. "Interns are essential staff in any office. They are full of potential, dreams and an optimistic perspective about their future careers. Tragically, another dream was taken away because of a senseless attack," Colyer said. "No one should head to our nation's capital to be an intern and not know if they're going to come home or not." USA TODAY has reached out to Estes' office. Greta Cross is a national trending reporter at USA TODAY. Story idea? Email her at gcross@ This article originally appeared on USA TODAY: 21-year-old congressional intern fatally in D.C., police say
Forbes
an hour ago
- Forbes
Trump Plan To Lower U.S. Drug Prices To Overseas Levels Lacks Details
President Donald Trump, accompanied by Health and Human Services Secretary Robert F. Kennedy Jr., ... More holds up an executive order aimed at reducing the cost of prescription pharmaceuticals during an event in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. The plan would tie U.S. drug prices to the ones paid in comparably wealthy foreign nations. (Photo by) Since President Trump issued an executive order in May that he claimed would lower prescription drug prices in the United States 'almost immediately by 30% to 80%," the administration has released no details regarding how the 'most favored nation' plan would be implemented. Such particulars may never emerge and without them a most favored nation model is likely a non-starter. The president's order aspires to implement a model known as most favored nation that ties the prices of prescription medicines in the U.S. to the lowest found among comparably wealthy nations. But even pharmaceutical executives, who represent the stakeholder most affected by the order, say the administration hasn't yet furnished them with details. At a Goldman Sachs Global Healthcare Conference last month, several pharmaceutical company executives noted a lack of clarity from the Trump administration as to how the program would be implemented. The only thing that's been made public about the most favored nation model is that the lowest price will be selected among comparably wealthy nations with at least 60% of the U.S. gross domestic product per capita. Specifically, according to a press release issued by the White House in late May, President Trump expects drug manufacturers to commit to 'aligning the prices of branded products' with the 'lowest price of a set of economic peer countries.' However, this only indicates who the comparator nations are. It doesn't list actual most favored nation price targets, which the executive order had promised HHS Secretary Robert F. Kennedy Jr. would 'communicate to pharmaceutical manufacturers to bring prices for American patients in line with comparably developed nations.' It also doesn't say whether calculations would account for differences in purchasing power between nations, not just GDP per capita. For a meaningful comparison, one needs to know how much a country's currency can buy in terms of goods and services. If not the federal government, then perhaps drug companies themselves could calculate the price targets. But this raises questions about which types of prices they'd use, publicly available list or proprietary net prices. If the latter, it's unclear whether this would violate contractual obligations. And it gets much more complicated for pharmaceutical firms. In calculating prescription drug price comparisons, simply computing the differences between prices isn't sufficient. Utilization disparities between nations must be weighted to yield an accurate, commensurate calculation. And differences in dosing and formulation must be accounted for. Since the executive order is to apply to branded medicines that do not currently have generic or biosimilar competition, it's unknown what to do if a particular drug doesn't have such competition in the U.S. but has generic or biosimilar competition in the most favored nation. This is a typical phenomenon among relatively high-cost biologics like the rheumatoid arthritis drug, Enbrel, and its referenced biosimilars which have been on the market across Europe for years and yet won't be in the U.S. until the end of this decade. Finally, the substantial differences in timing of approvals and launches of prescription drugs across countries make it hard if not impossible to create an international price index. Many recently approved branded medicines in the U.S. haven't yet been approved in other peer countries, let alone had their price determined by a government authority. The executive order's lack of details extends to the direct-to-consumer platform that it says would be established, through which American patients could buy their drugs directly from manufacturers who sell to Americans at the most favored nation price. HHS Secretary Kennedy was instructed to assist in creating such a mechanism. But how this would work remains a mystery to executives in the industry. Moreover, most drug companies aren't accustomed to selling their products directly to patients. And so, it would be quite an endeavor to build a platform from scratch. In the executive order, the president says that following the calculation of target prices, if drug companies don't doesn't voluntarily reduce prices the administration would 'propose a rulemaking plan to impose most-favored-nation pricing.' But the document doesn't disclose how—through which policy vehicle—the administration intends to pursue a rulemaking plan. One possibility is pursuit of a so-called demonstration project in the Medicare program. The executive branch has broad latitude to set up demonstration or pilot projects as it sees fit, under the authority granted the Center for Medicare and Medicaid Innovation by the Affordable Care Act. Here, CMMI's purpose is to test novel payment methods as well as care models, with the dual aim of lowering healthcare costs and improving the quality of care delivered to patients. But past experience shows the considerable limitations to what CMMI has been able to accomplish. There have been dozens of models proposed since the founding of CMMI. However, some of the proposed models, including ones on international price referencing, never got tested. And the majority of models that did get implemented failed to yield cost savings. Indeed, thus far only two have been made a permanent part of a public program: A diabetes and an accountable care organization demonstration project became permanent fixtures in Medicare. Most models ultimately get canceled, including recently a value-based insurance design initiative in Medicare Advantage. There are also logistical questions around the pursuit of a CMMI model for most favored nation drug pricing that need to be clarified. Would it be a voluntary or mandatory model? Until now, the vast majority of CMMI projects have been voluntary. The question becomes would healthcare providers in the so-called buy-and-bill space want to volunteer to participate in a system in which they potentially could get reimbursed less than the price at which they purchased products. If a most favored nation demonstration project were to be mandatory, this could lead to court challenges from physician groups in addition to the pharmaceutical industry. And then there's the issue of what the timeframe would be. Originally, the first Trump administration laid out a five-year period of gradual conversion towards an international price index that constituted a blend of U.S. and overseas prices. It appears that the second administration is far less patient and wants to achieve results as soon as possible. In announcing the most favored nation plan, President Trump posted on his social media platform in May that the prices of prescription medicines would fall "almost immediately" from 30% to 80% off of their current levels. But at this point in time, it's unknown how this would be achieved and whether the logistical and legal challenges could be overcome.
USA Today
2 hours ago
- USA Today
House clears key hurdle on tax megabill
On Thursday's episode of The Excerpt podcast: The House has cleared a hurdle on President Donald Trump's bill of legislative priorities. USA TODAY National Correspondent Marco della Cava puts Diddy's trial in context after a verdict. A federal judge has blocked President Trump's asylum ban at the U.S.-Mexico border. Kilmar Abrego Garcia experienced "severe beatings" and "psychological torture" at a prison in El Salvador, according to a new court filing. USA TODAY Youth Mental Health Reporting Fellow Rachel Hale discusses why LGBTQ+ youth are twice as likely to be homeless. Clayton Kershaw joins the 3,000 strikeout club. The U.S. men's soccer team advances to the Gold Cup Final to play Mexico. Hit play on the player below to hear the podcast and follow along with the transcript beneath it. This transcript was automatically generated, and then edited for clarity in its current form. There may be some differences between the audio and the text. Taylor Wilson: Good morning. I'm Taylor Wilson, and today is Thursday, July 3rd, 2025. This is USA TODAY's The Excerpt. Today the latest on Trump's mega bill as House lawmakers continue working, plus breaking down the verdict in Diddy's trial, and LGBTQ+ youth are twice as likely to be homeless. ♦ House Republicans have cleared a key procedural hurdle to get President Trump's signature legislative bill to his desk by a self-imposed July 4th deadline tomorrow. The House started debating Trump's legislative package of tax reductions and Medicaid cuts yesterday. But Republican leaders struggled to chart a path to victory with their narrow majorities in Congress. The House later voted 219 to 213 to move forward, setting up a final vote of yes or no on Trump's domestic agenda, ending taxes on tips and overtime, cutting Medicaid and bolstering border security. Still the vote doesn't guarantee the bill will succeed since several lawmakers who oppose its $3.3 trillion price tag are still seeking changes as of early this morning. You can stay up on all the latest with ♦ A verdict was delivered yesterday in the weeks-long trial of Sean Diddy Combs. I spoke with USA TODAY national correspondent Marco della Cava for more. And a heads-up, Marco had to join me while in transit, so apologies for the choppy audio. Thank you for joining me, Marco. Marco della Cava: Hey, thanks for having me in talking about this. Taylor Wilson: All right, so as for the verdict itself, what did we hear, and I guess what sentencing might Diddy now face? Marco della Cava: The jury took three days to deliberate, and Sean Combs basically got a pretty light verdict as it goes. Essentially, he was facing life in prison for racketeering, but that charge did not stick and the jury just found him guilty on essentially crossing state lines for prostitution. Taylor Wilson: What did we hear from witnesses throughout this trial, Marco, some of whom really put themselves and their intimate stories out there on the stand? Marco della Cava: Throughout the many weeks of test testimony, we heard essentially horrific stories from women about the abuse they suffered at the hands of Sean Combs. At the same time, many of these same women confessed that they loved him and did want to spend time with him, and were eager to really try and win him over. But at the same time, the defense teased out of many of them, essentially admissions that they really loved this man and they were really hoping to get him to commit to a serious relationship. And as a result of that desire, they went ahead with a lot of his wishes, which included them having sex with multiple other men. Often they cried on the stand, a couple of them testified anonymously. These were obviously people who are really shaken, if not broken by these experiences with this man. But in the end, obviously the jury did not feel that they were forced to do anything per se, even if many of them said, I felt in fear of my life and certainly in fear of my career disappearing if I said anything, if I brought this up. So in a sense, it's really something that is going to cause future witnesses in cases like this to think twice. Taylor Wilson: As for the defense approach to this case, I know you and I have previously talked about their concessions essentially, that Diddy was no saint. They kept leaning in on these claims. Was that part of their strategy in the waning days of this trial? And how did they also attempt to discredit the witnesses who testified? Marco della Cava: The defense essentially was saying that the witnesses were in a relationship with Combs and they knew what they were getting into, and therefore this is not a criminal issue. Taylor Wilson: You're right about the Me Too movement in this piece, Marco, what might be the legacy of the Diddy trial in the context of Me Too? Marco della Cava: Essentially, it's far different from R. Kelly. It's far different from Harvey Weinstein. It's essentially vindication for Sean Combs that he might have an extreme lifestyle. He might actually be an abuser, but that the government, in a sense cannot charge him with criminal activities in relationship to the way he lived his life. That, many people feel, will essentially cast a shadow over other future cases where women would maybe hesitate now to come forward and share their very painful stories with the world through court testimony. Taylor Wilson: Marco della Cava is a national correspondent with USA TODAY. Thanks, Marco. Marco della Cava: Thank you. ♦ Taylor Wilson: A federal judge has blocked President Donald Trump's asylum ban at the US-Mexico border saying Trump exceeded his authority when he issued a proclamation declaring illegal immigration and emergency and setting aside existing legal processes. The judge's opinion stated that Trump's January proclamation blocking all migrants engaged in the invasion across the southern border, as he put it from claiming asylum or other humanitarian protections went beyond his executive power. The American Civil Liberties Union brought the challenge to Trump's asylum ban in February, arguing it violated American laws and international treaties. Trump's border restrictions went beyond a similar ban put in place by former President Joe Biden in 2024. Key parts of the Biden ban were blocked by a separate federal judge in a lawsuit also led by the ACLU. Since Trump took office, the number of migrants caught crossing the border illegally as dropped to record lows. ♦ Kilmar Abrego Garcia experienced severe beatings in psychological torture in a notorious high security prison in El Salvador after he was deported by the Trump administration. According to a new court filing. The filing in federal court yesterday also says that Abrego Garcia experienced severe sleep deprivation and nutrition so inadequate that he lost 31 pounds while he was at the Terrorism Confinement Center, also known as CECOT in El Salvador. The new details from Abrego Garcia's treatment at CECOT come as part of a lawsuit filed by his wife against the Trump administration, which is seeking to have the matter thrown out because he has since been returned to the United States. An indictment accuses Abrego Garcia of conspiring to bring immigrants into the US illegally from various central and South American countries. He's pleaded not guilty. ♦ LGBTQ+ youth are twice as likely to be homeless. I spoke with USA TODAY Youth Mental Health reporting fellow Rachel Hale to learn more. Rachel, thanks for wrapping on. Rachel Hale: Thanks for having me. Taylor Wilson: So let's establish some of the data here at the top. What portion of young people experiencing homelessness are LGBTQ+ and how likely are LGBTQ+ youth to be homeless Rachel Hale: Though they make up 7% of the youth population, LGBTQ youth account for 40% of the young people experiencing homelessness in the United States and as a category LGBTQ youth are more than twice as likely to experience homelessness as their peers. Taylor Wilson: And Rachel, we should say also that Black, transgender and non-binary young people who report the highest indicators of poor mental health, face the highest risk of youth homelessness. In terms of all these numbers for young LGBTQ plus people in general, what are the contributing factors here, Rachel, what did you find? Rachel Hale: Part of it is that LGBTQ young people are less likely to access mental healthcare than their peers, partially because of affordability, but a lot of teens also cite not wanting to obtain permission from a parent. And we know that the largest cited reason and reports for homelessness from queer youth are people saying that they were shut out and rejected by their families. Taylor Wilson: So tell us about some of the young people you spoke with, Rachel, for this piece and their challenges with homelessness. Rachel Hale: So I spoke with some people who were younger and other people who had come out of the system years ago and were worried that the same stigma still existed or that enough hasn't been done to address the problem in this year since. One of those people was Eden Campbell McCollum. He told me that as a young person at 18 years old, he aged out of the foster care system and was sleeping on the number seven train in New York each night. He would take the subway to his job at Burger King and spent a lot of nights looping its route to Flushing. So it was the only place where he could get heat that provided kind of a brief break from New York City's winters. So again, someone who dealt with systemic issues coming out of the foster care system. But what complicated things is that he also had confusion about his gender identity. He didn't know any transgender people at the time, this would've been in the 1980s, and didn't have the language to describe what he was experiencing, but he knew he was different and that his parents wouldn't have accepted him. Someone one night saw him falling asleep on the train and connected him to Covenant House, one of the shelters in New York that was able to offer him care. But too many people are still going through the same thing that he experienced. Taylor Wilson: Wow. Well, as for this moment, specifically, Rachel, how are young members of this community navigating this climate under President Donald Trump and some of his administration's cuts? Rachel Hale: Advocates say that concerns for homeless youth are really heightened right now. Most recently on June 17th, the administration instructed the 988 Suicide and Crisis Lifeline to end its specialized services for LGBTQ youth. Within the next month, nearly 1.3 million young LGBTQ people have used support from that hotline since its launch in 2022. A day later, the Supreme Court also upheld Tennessee's ban on gender-affirming care for minors. So there's a number of things that have changed in the current administration that have led people to have additional concern about visibly being queer and also about seeking LGBTQ specific care. Taylor Wilson: What's the answer here? I mean, is there a solution to this devastating problem? Rachel Hale: I think that advocates who have been through this system are always trying to think of what that answer looks like. But one thing that the people I spoke with kept coming back to was that the services they accessed at these youth shelters we're really vital. So for example, Eden told me that making sure that young homeless people are having access to life skills building programs. So looking at how a checking account works and what it means to have a statement come through every month from your credit card. Just those basic things that you might not learn growing up. Another thing that Eden said is that accessing queer spaces in their youth were really important. Communities where there are other LGBTQ youth and life skill specific training are two really important things. And also amid current changes in the administration, continuing to make sure that there are spaces where LGBTQ youth feel welcome. Taylor Wilson: All right, another great piece from you Rachel. Rachel Hale covers youth mental health for USA TODAY. Thanks, Rachel. Rachel Hale: Thank you so much. ♦ Taylor Wilson: Clayton Kershaw has joined an exclusive club. The longtime Los Angeles Dodgers ace last night became the 20th pitcher in Major League baseball history to strike out 3000 batters. You can read more about his storied career and why his manager called him a unicorn with a link in today's show notes. ♦ US Men's National Soccer Team took down Guatemala last night, two to one to make the Gold Cup Final. He'll take on Mexico on Sunday after Mexico beat Honduras last night in the nightcap. You can follow along with USA Today Sports. ♦ And later today, can an AI chatbot be your therapist? Some bots are masquerading as licensed therapists and are failing in dangerous ways. Vaile Wright: The challenge is that because these AI chatbots are not being monitored by humans who know what good mental health care is, they go rogue and they say very harmful things. Taylor Wilson: Dale Wright a psychologist with the American Psychological Association, sat down with my colleague Dana Taylor, to discuss the real world implications of unmonitored AI therapists and what can be done to make them better. You can catch that conversation later today, beginning at 4:00 PM Eastern Time. ♦ Thanks for listening to The Excerpt. You can get the podcast wherever you get your audio, and as always, you can find us on email@ I'm Taylor Wilson. I'll be back tomorrow with more of The Excerpt from USA TODAY.
